#susceptibility — Monday, July 13, 2026 (1 items)
| 0 | ℹ |
Cefiderocol nonsusceptibility among carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-07-13 | #amr #susceptibility #carbapenem-resistance #surveillance |